This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heartfailure monitoring detected twice as many heartfailure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.
Genesis is the latest advancement in Robotic Magnetic Navigation technology. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern.
recently announced that Digitiva, a non-invasive digital health solution for heartfailure management, has been listed with the U.S. a smartphone app designed for heartfailure patients and built on the Welldoc, Inc. tim.hodson Thu, 09/19/2024 - 09:42 Sept. 18, 2024 – Astellas Pharma Inc.
(MedPage Today) -- CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heartfailure (HF) hospitalization for this technology.
Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heartfailure patient on February 13, 2024 at Henry Ford Hospital in Detroit. Other symptoms include swelling in the abdomen, legs or neck veins.
FIRE1s Norm heartfailure management system offers a unique approach for patients to manage heartfailure. The company also announced Ellie McGuire, Partner at Polaris Partners, and Michael Wasserman, Partner and COO at Elevage Medical Technologies have joined its Board of Directors.
Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. As electrophysiologists, our primary goal is to improve the lives of our patients,” said Dr. Mario Volpicelli , Head of the Electrophysiology Unit of the hospital. added Giuseppe Russo, General Manager of the Hospital Santa Maria della Pietà. “We
The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heartfailure, and sudden cardiac arrest.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. The CaRi-Hearttechnology is in clinical use in the UK, European Union, and Australia.
American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: HeartFailure Reveals that Despite Significant Efforts to Improve Acute HeartFailure Treatment Over the Past 20 Years, Management Remains Unchanged 3.
ObjectivesTelenursing in cardiac care leverages technology to support self-care and optimize outcomes for heartfailure patients during and beyond the pandemic.
12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heartfailure andcardiogenic shock. and Impella CP enable heart recovery as part of the world's smallest heart pump platform. with SmartAssist tim.hodson Wed, 12/18/2024 - 14:06 Dec.
Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heartfailure monitoring. The FIRE1 System is the first device designed to directly measure a patient’s volume status by measuring the largest vein in the body where most fluid is stored – the inferior vena cava (IVC) – to better manage heartfailure.
Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.
Food and Drug Administration ( FDA ) granted an Investigational Device Exemption (IDE) to initiate a US Pivotal Study with its technology. This patient population lacks approved therapeutic options, leading to a poor prognosis with many recurrent hospitalizations and reduced life expectancy. Javits Convention Center, North.
In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heartfailure, coronary artery disease, vascular disease and atrial fibrillation.
Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heartfailure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.
2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heartfailure. Nicholas S.
Since the implantation of the first pacemakers in the 1960s, rapid advancements in biomedical technologies have led to the development of Cardiac Resynchronization Therapy (CRT) in the 1990s. 1,2) Moreover, now evidence on CRT upgrade with hard outcome is also available for patients with HFrEF and wide, paced QRS (3).
He led the structural heart program and cardiac catheterization laboratory at the University of Cincinnati and spent several years with The Christ Hospital in Ohio. There, he served as an investigator in many high-profile clinical trials, including several significant structural heart studies.
“Comprehensive echocardiographic exam with a 5G cellular network and robotic arm-based remote system is feasible with relatively good diagnostic accuracy,” said study author Dr Yu Liu, Zhongshan Hospital, Shanghai, China. However, this expertise is often limited or unavailable in rural or indeed smaller urban areas.
History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.
Recent technological advances, pathophysiology, and pharmacotherapy have contributed to a near-universal recognition of the overlap between cardiovascular, kidney, and metabolic diseases. Depression symptoms linked to increased hospitalization rates in patients with CKD.
All About Cardiac Remote Patient Monitoring Software Comprehensive healthcare for rhythm, heartfailure, and hypertension requires the ability to monitor a heart’s condition. Cardiac implantable devices are sophisticated technology that provide both therapy and diagnostics for patients with irregular heart rhythms.
For the sickest of cardiac patients, those who are leaving the hospital with advanced heartfailure or who just had a heart attack, Virtual-First cardiology enables frequent virtual visits driven by AI-driven algorithms which identify the most pressing risks.
The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heartfailure (ADHF) who are unresponsive to standard medical therapy. I am excited to be able to include the advanced heartfailure patients in the trial," commented Dr. Grafton.
healthcare providers can now detect Low EF, a key heartfailure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. As a result, many heartfailure cases go undiagnosed until symptoms force a specialist or emergency hospital visit, leading to worse patient outcomes and exacerbated healthcare costs.2
AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions. By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable.
CMS has reviewed the CardiAMP HeartFailure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP HeartFailure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,
Results showed reductions in heart death equivalents and MACCE, with a magnified reduction among patients with elevated NTproBNP, a common marker of heart distress. These patients saw more than a 17% lower rate of heart death equivalents at up to two years compared to control patients treated with heartfailure medication alone (2.9%
This advanced imaging technology allows me and my fellow clinicians to perform complex cardiology interventions with a high level of precision and exceptional image quality,” said Sean Mazer , M.D., FHRS, FACC, electrophysiologist and president of the New Mexico Heart Institute/Lovelace Medical Group *. It’s an honor to have the U.S.’s
1,2 People living with AFib face an increased risk of stroke, heartfailure and death, and many rely on cardiac ablation to treat the condition effectively. Helmut Puererfellner at Ordensklinikum hospital in Linz, Austria; Prof. Roland Tilz at the University Heart Center in Luebeck, Germany; Prof.
a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of HeartFailure. The manuscript is available online at the European Journal of HeartFailure website.
BackgroundTelemedicine interventions (TMIs) for heartfailure (HF) can reduce hospitalizations and deaths. It is unclear if low literacy and limited access to technology in low and middleincome countries affect these benefits. Patients hospitalized because of HF were randomized to usual care or a multicomponent TMIs.
The primary effectiveness endpoint was a composite of death, heart transplant/left ventricular assist device (LVAD) implantation, HF hospitalization, outpatient HF worsening, and quality of life. Food and Drug Administration's Breakthrough Devices Program and enrolled patients at 101 hospitals in 11 countries, including in the U.S.,
30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By
The Aria CV Pulmonary Hypertension System is an implantable gas-filled balloon that is introduced percutaneously and functions in the main pulmonary artery to alleviate the excessive workload on the right heart that results in right heartfailure.
Do the healthcare clinics have the tools and technologies needed for diagnosing complicated heart conditions? Are there effective cardiovascular treatment reporting software available within the hospitals? Take a look at some of the challenges faced by the hospitals.
Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation , director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital, and co-principal investigator of the TRILUMINATE Pivotal trial.
Compared to their peers without the condition, people with atrial fibrillation are twice as likely to be admitted to hospital, five times more likely to have a stroke, three times more likely to develop heartfailure, and twice as likely to die prematurely.4 The risk of death is extremely low (0.05-0.1%).
Last ECG: Final Diagnosis: "NSTEMI" This patient will likely suffer heartfailure and early death due to the diagnosis of "NSTEMI" Learning Points: Despite NSTEMI guidelines recommending emergent angiography for NSTEMI patients with refractory ischemic symptoms, this is simply not done in many systems, and this has been recorded in a study as well.
I’ve worked with hospitals, provider groups and payers – trying to help drive the right type of access, care, and value across the healthcare continuum. 1 That problem is exacerbated by the lack of access to acute care: Since 2011, two-thirds of the hospital closures in the U.S. have been in rural areas. So what is the way forward?
As we all know, early diagnosis of such diseases is crucial in order to prevent patients from suffering heartfailure or sudden death. The hospital needed a new solution to deal with the consequences of an increasing demand for healthcare services, workforce shortages, and the rising costs of care.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content